Weighed Down by Opioid Litigation, Endo International Files for Bankruptcy

Text size Dreamstime The generic drugmaker Endo International , which faces thousands of lawsuits related to its alleged role in the opioid crisis, filed for bankruptcy late Tuesday morning, while ann...

Endo International Files for Bankruptcy to Weather Opioid Lawsuits

Endo International PLC became the latest pharmaceutical company to file for bankruptcy under the weight of lawsuits alleging it played a role in fueling the opioid crisis. The drugmaker, domiciled in ...

Buying From Mark Cuban’s Pharmacy Could Save Medicare Billions, Study Says

Medicare’s prescription-drug program could save billions of dollars annually if it purchased generic acid-reflux, cancer and other drugs from a new pharmacy backed by investor Mark Cuban, according to...

Teva CEO Sees a Final Opioid Settlement Coming This Year

Text size Teva CEO Kåre Schultz has been predicting a national opioid settlement for years. Christopher Goodney/Bloomberg Teva Pharmaceutical Industries CEO Kåre Schultz has, for years, been predictin...

Viatris stock slides 24% as analysts say sale of biosimilars to Indian partner removes key growth driver

Viatris Inc. said Monday it has agreed to combine its biosimilars portfolio with privately held Indian company Biocon Biologics Ltd. for up to $3.335 billion, as part of a broader overhaul of its busi...

Viatris to Sell Biosimilars Business for $3 Billion. Shares Tumble.

Viatris will sell the biosimilars business of the former Mylan to the Indian drugmaker Biocon for as much as $3.3 billion. Dreamstime Text size Viatris , the company formed in 2020 through a merger of...

5 Companies That Began 2022 With Upbeat News on Dividends

Royalty Pharma, Life Storage, and Viatris, among other companies, rang in 2022 by announcing dividend increases this week. Royalty Pharma (ticker: RPRX) declared a quarterly dividend of 19 cents a sha...